Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-29,369
Closed -$851K 1115
2022
Q4
$851K Sell
29,369
-95,400
-76% -$2.63M ﹤0.01% 913
2022
Q3
$2.44M Buy
124,769
+68,900
+123% +$1.42M 0.01% 725
2022
Q2
$1.11M Buy
55,869
+47,310
+553% +$1.07M ﹤0.01% 863
2022
Q1
$210K Buy
+8,559
New +$198K ﹤0.01% 1149
2021
Q4
Sell
-9,029
Closed -$202K 1181
2021
Q3
$202K Hold
9,029
﹤0.01% 1194
2021
Q2
$232K Buy
+9,029
New +$220K ﹤0.01% 1210
2021
Q1
Sell
-30,193
Closed -$462K 1227
2020
Q4
$462K Sell
30,193
-271
-0.9% -$3.01K ﹤0.01% 1080
2020
Q3
$243K Sell
30,464
-7,571
-20% -$73K ﹤0.01% 1131
2020
Q2
$371K Buy
+38,035
New +$349K ﹤0.01% 1105
2018
Q4
Sell
-21,800
Closed -$950K 1308
2018
Q3
$950K Hold
21,800
﹤0.01% 1044
2018
Q2
$910K Buy
+21,800
New +$892K ﹤0.01% 1024

Other funds holding CHX

Axa's CHX Position: Q1 2023 in Review

Axa sold out of ChampionX (CHX) in Q1 2023, closing a stake of 29,369 shares — an estimated $851K sold.

Axa first reported a position in CHX in Q2 2018 and held it in 11 quarters. The position peaked at $2.44M in Q3 2022. 373 funds tracked by Wall St. Rank hold CHX as of Q1 2023.

  • Axa reported no remaining ChampionX position as of Q1 2023 after selling out during the quarter.
  • Axa sold 29,369 ChampionX shares in Q1 2023, an estimated $851K.
  • Axa first reported a position in ChampionX in Q2 2018 and held it in 11 quarters.
  • Axa's ChampionX position peaked at $2.44M in Q3 2022.
  • 373 funds tracked by Wall St. Rank held ChampionX as of Q1 2023.

Based on Axa's 13F filing for Q1 2023, filed 15 May 2023.